Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Sees “Similar” Payments For “Similar” Products In Upcoming OPPS Rule

Executive Summary

The Centers for Medicare & Medicaid Services' upcoming proposed Hospital Outpatient Prospective Payment System rule is likely to include "similar" levels of reimbursement for therapies that have "similar clinical effects," Office of Clinical Standards & Quality Acting Director Sean Tunis, MD, said

You may also be interested in...

CMS Defends “Functional Equivalence”; AWP Proposal Ready, Scully Says

The Centers for Medicare & Medicaid Services is sticking to its position that deeming Amgen's Aranesp "functionally equivalent" to Johnson & Johnson's Procrit is the best approach to handling the product under the Hospital Outpatient Prospective Payment System

Aranesp, Procrit Are “Functionally Equivalent,” CMS Says In Final OPPS Rule

The National Cancer Institute will conduct a head-to-head study of Amgen's Aranesp (darbepoetin) and Ortho's Procrit (epoetin) in order to define equivalent doses of the anemia agents, CMS reports in the final Hospital Outpatient Prospective Payment System rule for 2003

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts